Skip to main content
. 2016 Dec 29;32(3):439–447. doi: 10.3346/jkms.2017.32.3.439

Table 2. Comparisons of pH, PaO2, and PaCO2 in ACOS patients with different disease severity and healthy controls before and after treatment.

Group pH PaO2, mmHg PaCO2, mmHg
Before treatment After treatment P Before treatment After treatment P Before treatment After treatment P
Control 7.45 ± 0.05 7.46 ± 0.04 0.064 71.89 ± 7.19 70.70 ± 4.63 0.139 41.56 ± 3.59 41.01 ± 3.23 0.142
Mild ACOS 7.27 ± 0.04* 7.46 ± 0.03 < 0.001 65.38 ± 7.02* 70.04 ± 4.55 0.018 44.51 ± 6.50* 40.76 ± 3.83 0.007
Moderate ACOS 7.24 ± 0.03* 7.45 ± 0.02 < 0.001 59.06 ± 6.85* 71.01 ± 4.51 < 0.001 48.10 ± 5.16* 40.08 ± 3.17 < 0.001
Severe ACOS 7.21 ± 0.03* 7.37 ± 0.03 < 0.001 53.06 ± 8.32* 64.74 ± 4.47 < 0.001 52.62 ± 6.23* 45.71 ± 2.99 < 0.001
Extremely severe ACOS 7.18 ± 0.02* 7.35 ± 0.02 < 0.001 46.95 ± 13.81* 63.47 ± 12.98 < 0.001 56.35 ± 5.37* 46.35 ± 4.08 < 0.001

ACOS = asthma-chronic obstructive pulmonary disease overlap syndrome, PaO2 = arterial oxygen partial pressure, PaCO2 = partial pressure of carbon dioxide in artery.

*P < 0.05, compared with the control group before treatment; P < 0.05, compared with the control group after treatment.